Correlation between overactive bladder and detrusor overactivity: a retrospective study.
Detrusor overactivity
Overactive bladder
Predictive model
Urodynamic study
Validated questionnaire
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
24
03
2022
accepted:
01
06
2022
medline:
28
3
2023
pubmed:
26
6
2022
entrez:
25
6
2022
Statut:
ppublish
Résumé
The primary objective of this study is to determine the prevalence of overactive bladder (OAB) and detrusor overactivity (DO) in female patients who were referred for urodynamic study (UDS) because of lower urinary tract symptoms (LUTS). The secondary objective is to determine the subjective and objective differences between female OAB patients with and without DO. All female patients who underwent UDS for LUTS between June 2016 and September 2019 were retrospectively reviewed. Personal history, medical history, physical examination, and validated questionnaires were collected. One-hour pad test and multichannel urodynamic study was performed. All statistical analyses were conducted by SAS 9.4. P-value < 0.05 was considered statistically significant. A total of 4184 female patients underwent UDS because of LUTS between June 2016 and September 2019; 1524 patients were analyzed for OAB or DO. The occurrence of OAB was 36.4%. The overall incidence of DO in OAB patients was 15.5%; 9.5% of all patients had DO findings on UDS, and 4.6% were incidental findings. There were significant differences among mean age, parity, ICIQ-UI SF, OABSS, POPDI-6, and all UDS parameters (except for maximal urethral pressure and pressure transmission ratio) between patients with and without DO. In patients with DO, there were no significant differences among age, parity, and BMI with or without OAB symptoms. However, there were significant differences among mean OABSS, ICIQ-UI SF, UDI-6, POPDI-6, IIQ-7, and pad test. Patients with DO are associated with older age, increased parity, greater urine leakage, and worse storage and micturition functions on UDS. Combinations of subjective and objective measurements are better predictive models for OAB patients.
Identifiants
pubmed: 35751673
doi: 10.1007/s00192-022-05274-7
pii: 10.1007/s00192-022-05274-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
867-875Informations de copyright
© 2022. The International Urogynecological Association.
Références
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN, International Urogynecological A, International Continence S. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. https://doi.org/10.1002/nau.20798 .
doi: 10.1002/nau.20798
pubmed: 19941278
Rosier P, Schaefer W, Lose G, Goldman HB, Guralnick M, Eustice S, Dickinson T, Hashim H. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2017;36(5):1243–60. https://doi.org/10.1002/nau.23124 .
doi: 10.1002/nau.23124
pubmed: 27917521
Hashim H, Abrams P. Is the Bladder a Reliable Witness for Predicting Detrusor Overactivity? J Urol. 2006;175(1):191–4. https://doi.org/10.1016/s0022-5347(05)00067-4 .
doi: 10.1016/s0022-5347(05)00067-4
pubmed: 16406907
Haylen BT, Chetty N, Logan V, Schulz S, Verity L, Law M, Zhou J. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(2):123–8. https://doi.org/10.1007/s00192-006-0165-z .
doi: 10.1007/s00192-006-0165-z
pubmed: 16823541
Brown ET, Krlin RM, Winters JC. Urodynamics: examining the current role of UDS testing. What is the role of urodynamic testing in light of recent AUA urodynamics and overactive bladder guidelines and the VALUE study? Curr Urol Rep. 2013;14(5):403–8. https://doi.org/10.1007/s11934-013-0361-6 .
doi: 10.1007/s11934-013-0361-6
pubmed: 23904217
Verghese TS, Middleton LJ, Daniels JP, Deeks JJ, Latthe PM. The impact of urodynamics on treatment and outcomes in women with an overactive bladder: a longitudinal prospective follow-up study. Int Urogynecol J. 2018;29(4):513–9. https://doi.org/10.1007/s00192-017-3414-4 .
doi: 10.1007/s00192-017-3414-4
pubmed: 28721482
Robinson D, Staskin D, Laterza RM, Koelbl H. Defining female voiding dysfunction: ICI-RS 2011. Neurourol Urodyn. 2012;31(3):313–6. https://doi.org/10.1002/nau.22213 .
doi: 10.1002/nau.22213
pubmed: 22415792
Cho KJ, Kim HS, Koh JS, Kim JC. Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction. Int Braz J Urol. 2015;41(4):722–8. https://doi.org/10.1590/s1677-5538.Ibju.2014.0195 .
doi: 10.1590/s1677-5538.Ibju.2014.0195
pubmed: 26401865
pmcid: 4757001
Serati M, Topazio L, Bogani G, Costantini E, Pietropaolo A, Palleschi G, Carbone A, Soligo M, Del Popolo G, Li Marzi V, Salvatore S, Finazzi Agrò E. Urodynamics useless before surgery for female stress urinary incontinence: Are you sure? Results from a multicenter single nation database. Neurourol Urodyn. 2016;35(7):809–12. https://doi.org/10.1002/nau.22804 .
doi: 10.1002/nau.22804
pubmed: 26061435
Hung MJ, Chou CL, Yen TW, Chuang YC, Meng E, Huang ST, Kuo HC. Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study. J Formos Med Assoc. 2013;112(5):276–82. https://doi.org/10.1016/j.jfma.2011.09.020 .
doi: 10.1016/j.jfma.2011.09.020
pubmed: 23660224
Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30. https://doi.org/10.1002/nau.20041 .
doi: 10.1002/nau.20041
pubmed: 15227649
Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res. 1994;3(5):291–306. https://doi.org/10.1007/BF00451721 .
doi: 10.1007/BF00451721
pubmed: 7841963
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13. https://doi.org/10.1016/j.ajog.2004.12.025 .
doi: 10.1016/j.ajog.2004.12.025
pubmed: 16021067
Su TH, Lau HH. Validation of a Chinese version of the short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire. J Sex Med. 2010;7(12):3940–5. https://doi.org/10.1111/j.1743-6109.2010.01891.x .
doi: 10.1111/j.1743-6109.2010.01891.x
pubmed: 20626603
Chen SL, Ng SC, Huang YH, Chen GD. Are patients with bladder oversensitivity different from those with urodynamically proven detrusor overactivity in female overactive bladder syndrome? J Chin Med Assoc. 2017;80(10):644–50. https://doi.org/10.1016/j.jcma.2017.03.009 .
doi: 10.1016/j.jcma.2017.03.009
pubmed: 28757173
Baumeister P, Kozomara M, Seifert B, Mehnert U, Kessler TM. Detrusor overactivity is missed by stopping urodynamic investigation at a bladder volume of 500 mL. BJU Int. 2019;124(5):870–5. https://doi.org/10.1111/bju.14868 .
doi: 10.1111/bju.14868
pubmed: 31298777
Klevmark B. Volume threshold for micturition. Influence of filling rate on sensory and motor bladder function. Scand J Urol Nephrol Suppl. 2002;210:6–10. https://doi.org/10.1080/003655902320765890 .
doi: 10.1080/003655902320765890
de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn. 2010;29(1):30–9. https://doi.org/10.1002/nau.20858 .
doi: 10.1002/nau.20858
pubmed: 20025017
Burrows LJ, Meyn LA, Walters MD, Weber AM. Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol. 2004;104(5 Pt 1):982–8. https://doi.org/10.1097/01.AOG.0000142708.61298.be .
doi: 10.1097/01.AOG.0000142708.61298.be
pubmed: 15516388
Rovner ES, Goudelocke CM. Urodynamics in the evaluation of overactive bladder. Curr Urol Rep. 2010;11(5):343–7. https://doi.org/10.1007/s11934-010-0130-8 .
doi: 10.1007/s11934-010-0130-8
pubmed: 20585906
Guralnick ML, Grimsby G, Liss M, Szabo A, O'Connor RC. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity. Int Urogynecol J. 2010;21(3):325–9. https://doi.org/10.1007/s00192-009-1030-7 .
doi: 10.1007/s00192-009-1030-7
pubmed: 19907912
Juszczak K, Ziomber A, Wyczolkowski M, Thor PJ. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats. J Physiol Pharmacol. 2009;60(4):85–91.
pubmed: 20065501
Blaivas JG. The Bladder is an Unreliable Witness. Neurol Urodynam. 1996;15:443–5.
doi: 10.1002/(SICI)1520-6777(1996)15:5<443::AID-NAU1>3.0.CO;2-F
Giarenis I, Musonda P, Mastoroudes H, Robinson D, Cardozo L. Can we predict detrusor overactivity in women with lower urinary tract symptoms? The King's Detrusor Overactivity Score (KiDOS). Eur J Obstet Gynecol Reprod Biol. 2016;205:127–32. https://doi.org/10.1016/j.ejogrb.2016.07.495 .
doi: 10.1016/j.ejogrb.2016.07.495
pubmed: 27592416
Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE. What Type of Urinary Incontinence Does This Woman Have? JAMA. 2008;299(12):1446–56.
doi: 10.1001/jama.299.12.1446
pubmed: 18364487
Malone-Lee JG, Al-Buheissi S. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study. BJU Int. 2009;103(7):931–7. https://doi.org/10.1111/j.1464-410X.2009.08361.x .
doi: 10.1111/j.1464-410X.2009.08361.x
pubmed: 19281469
Patel B, Choe J, Lee U, Lucioni A, Washington B, Govier F, Kobashi K. Volume at urodynamic detrusor overactivity predicts success with InterStim. J Urol. 2013;189(4S):e929.
doi: 10.1016/j.juro.2013.02.2195
Lee SR, Kim HJ, Kim A, Kim JH. Overactive bladder is not only overactive but also hypersensitive. Urology. 2010;75(5):1053–9. https://doi.org/10.1016/j.urology.2009.10.045 .
doi: 10.1016/j.urology.2009.10.045
pubmed: 20092879
Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Gamé X, Kirby R, Van Der Aa F, Cornu JN. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988–1000. https://doi.org/10.1016/j.eururo.2019.02.038 .
doi: 10.1016/j.eururo.2019.02.038
pubmed: 30922690
Kim TH, Lee KS. Persistence and compliance with medication management in the treatment of overactive bladder. Investig Clin Urol. 2016;57(2):84–93. https://doi.org/10.4111/icu.2016.57.2.84 .
doi: 10.4111/icu.2016.57.2.84
pubmed: 26981589
pmcid: 4791665